-
Pre-market Decliners: ImmunoGen (NASDAQ:IMGN), Finish Line Inc. (NASDAQ:FINL), Biogen Idec Inc. (NASDAQ:BIIB), Yandex N.V. (NASDAQ:YNDX), ARM Holdings plc (NASDAQ:ARMH)
On Dec 15, ImmunoGen, Inc. (NASDAQ:IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, announced that Daniel Junius, President and CEO, will present at the upcoming 33rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for 9:00 am PT (12:00 pm ET) on January 13,…
-
Stocks Buzz: GlaxoSmithKline plc (NYSE:GSK), ChinaCache International Holdings (NASDAQ:CCIH), Vimicro International Corp. (NASDAQ:VIMC), AmeriGas Partners LP (NYSE:APU), Finish Line Inc. (NASDAQ:FINL)
GlaxoSmithKline plc (NYSE:GSK) has been given an “A+” credit rating by analysts at Morningstar. The research firm’s “A+” rating suggests that the company is a low default risk. They also gave their stock a three star rating. GlaxoSmithKline plc (NYSE:GSK) in last trading activity fell -1.41% to close at $43.49. Company weekly performance is -6.89%…
-
Stocks Gaining Momentum: Frontier Communications Corporation (NASDAQ:FTR), AstraZeneca PLC (NYSE:AZN), Tel-Instrument Electronics Corp. (NYSEMKT:TIK), Hewlett-Packard Company (NYSE:HPQ), Finish Line Inc. (NASDAQ:FINL)
Frontier Communications Corporation (NASDAQ:FTR) on Monday updated its 2014 guidance for the investment community to include the completion of its fourth-quarter Connecticut market acquisition. Frontier Communications Corporation (NASDAQ:FTR) in last trading activity fell -5.22% to close at $6.54. Company weekly performance is -5.90% while its quarterly performance stands at -1.36%. Frontier Communications Corporation (NASDAQ:FTR) is…
-
Top Wall Street Stories: Actavis plc (NYSE:ACT), MetLife (NYSE:MET), Companhia Brasileira de Distribuicao (NYSE:CBD), Finish Line Inc. (NASDAQ:FINL), Hibbett Sports (NASDAQ:HIBB)
Actavis PLC (NYSE:ACT) agreed to pay about $66 billion for Allergan Inc., the maker of the antiwrinkle treatment Botox, in the year’s biggest pharmaceutical deal. Actavis plc (NYSE:ACT) in last trading activity increased 1.71% to close at $247.94. Company weekly performance is 0.90% while its quarterly performance stands at 11.14%. Actavis plc (NYSE:ACT) is -2.54%…
-
Worth Watching Stocks: Freeport-McMoRan Inc. (NYSE:FCX), American Eagle Outfitters(NYSE:AEO), Finish Line Inc. (NASDAQ:FINL), Chicago Bridge & Iron Company (NYSE:CBI), AETI
Freeport-McMoRan Inc. (NYSE:FCX) is scheduled to issue its quarterly earnings data on Tuesday, October 28th. Freeport-McMoRan Inc. (NYSE:FCX) in last trading activity moved down -0.52% to close at $30.80. Company weekly performance is 1.52% while its quarterly performance stands at -18.26%. Freeport-McMoRan Inc. (NYSE:FCX) is -20.32% away from its 52 week high. American Eagle Outfitters…
-
Top Wall Street Stories: Amazon.com(NASDAQ:AMZN), Weibo Corporation (NASDAQ:WB), Time Warner (NYSE:TWX), Wal-Mart Stores (NYSE:WMT), Finish Line Inc. (NASDAQ:FINL)
On 24th September Amazon.com, Inc. (NASDAQ:AMZN) introduces #AmazonWishList, allowing customers to add items to their Amazon Wish List without leaving Twitter. Customers who discover a Tweet from their favorite artist, expert, brand, or friend with an Amazon.com product link, can simply add “#AmazonWishList” to the reply on Twitter and the product is added to their…
-
Momentum Stocks – GILD, AMZN, IBM, VZ, EBAY, PG, MYGN, CBST
Gilead Sciences, Inc. (NASDAQ:GILD) rose +1.8% . After Gilead Sciences, Inc. (NASDAQ:GILD) said, that FDA approves once-daily single tablet HIV-1 regimen Complera for patients switching from a stable regimen. Shares of Gilead Sciences, Inc. (NASDAQ:GILD) were increased 0.53% to $71.80 in premarket. In last session GILD closed at $71.42. Amazon.com, Inc. (NASDAQ:AMZN) shares rose +0.8%.…